Home
Conditions
Neoplasms, Neuroepithelial

Clinical trial condition

Neoplasms, Neuroepithelial

Explore clinical trials studying Neoplasms, Neuroepithelial. Study availability and eligibility vary by location and protocol.

2,956 public trials 647 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms, Neuroepithelial trial results

Completed

Multicenter Pilot-study for the Therapy of Medulloblastoma of Adults

NCT01614132

Conditions: Glioma, Medulloblastoma, Neoplasms, +7 more
Locations: Vivantes Netzwerk für Gesundheit GmbH Berlin, Germany

Neurologische Universitätsklinik Bochum, Germany

Universitätsklinikum Bonn Bonn, Germany

Universitätsklinikum Freiburg Freiburg im Breisgau, Germany

View all 15 locations

View Trial Details

Completed

Protracted Etoposide During Induction Therapy for High Risk Neuroblastoma

NCT00578864

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations: Texas Children's Hospital Houston, Texas, United States

View Trial Details

Completed

Nivolumab With DC Vaccines for Recurrent Brain Tumors

NCT02529072

Conditions: Astrocytoma, Glioblastoma, Glioma, +8 more
Locations: Duke University Medical Center Durham, North Carolina, United States

View Trial Details

Completed

Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM)

NCT01067469

Conditions: Astrocytoma, Brain Cancer, Brain Diseases, +15 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK525762 in Subjects With NUT Midline Carcinoma (NMC) and Other Cancers

NCT01587703

Conditions: Blood Protein Disorders, Bronchial Neoplasms, Carcinoma, +31 more
Locations: GSK Investigational Site Baltimore, Maryland, United States

GSK Investigational Site Boston, Massachusetts, United States

GSK Investigational Site Philadelphia, Pennsylvania, United States

GSK Investigational Site Nashville, Tennessee, United States

View all 17 locations

View Trial Details

Completed

High-Risk Neuroblastoma Chemotherapy Without G-CSF

NCT02786719

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations: Rady Children's Hospital San Diego, California, United States

Texas Children's Hospital Houston, Texas, United States

View Trial Details

Completed

Study of a c-Met Inhibitor PLB1001 in Patients With PTPRZ1-MET Fusion Gene Positive Recurrent High-grade Gliomas

NCT02978261

Conditions: Glioma, Neoplasms, Neoplasms by Histologic Type, +5 more
Locations: Beijing Shijitan Hospital,CMU Beijing, Beijing Municipality, China

View Trial Details

Completed

Anti-GD2 3F8 Monoclonal Antibody and GM-CSF for High-Risk Neuroblastoma

NCT02100930

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

ANG1005 in Patients With Recurrent High-Grade Glioma

NCT01967810

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +19 more
Locations: Moores UC San Diego Cancer Center La Jolla, California, United States

Northwestern University Chicago, Illinois, United States

Massachusetts General Hospital Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View Trial Details

Completed

Imiquimod and Tumor Lysate Vaccine Immunotherapy in Adults With High Risk or Recurrent Grade II Gliomas

NCT01678352

Conditions: Glioma, Hemic and Lymphatic Diseases, High Risk WHO Grade II Glioma, +15 more
Locations: University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States

View Trial Details

Neoplasms, Neuroepithelial

Neoplasms, Neuroepithelial trial results

Related conditions